Ó£ÌÒÊÓƵ

Rewriting human health,

one cell at a time

Products | ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

iocells_vial_radial_0

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

bitbio-platform_diagram-horizontal-no_BG-V2.1 bitbio-platform_diagram-vertical-no_BG-min

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

Latest news

Ó£ÌÒÊÓƵ launches first-of-their-kind human iPSC-derived cells for gene activation and interference, expanding functional genomics product range Press Release
Ó£ÌÒÊÓƵ launches first-of-their-kind human iPSC-derived cells for gene activation and interference, expanding functional genomics product range 03.03.2025
Published by Ó£ÌÒÊÓƵ
Read now
Ó£ÌÒÊÓƵ Launches ioTracker Cells Range at SLAS 2025 Press Release
Ó£ÌÒÊÓƵ Launches ioTracker Cells Range at SLAS 2025 03.02.2025
Published by Ó£ÌÒÊÓƵ
Read now
Ó£ÌÒÊÓƵ Raises $30 Million Led by M&G Investments Press Release
Ó£ÌÒÊÓƵ Raises $30 Million Led by M&G Investments 16.12.2024
Published by Ó£ÌÒÊÓƵ
Read now
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers News
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers 17.10.2024
Published by Ó£ÌÒÊÓƵ
Read now